Ensign Peak Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $817K | Hold |
26,094
| – | – | ﹤0.01% | 1365 |
|
|
2025
Q1 | $875K | Hold |
26,094
| – | – | ﹤0.01% | 1325 |
|
|
2024
Q4 | $1.02M | Sell |
26,094
-136,970
| -84% | -$5.37M | ﹤0.01% | 1306 |
|
|
2024
Q3 | $6.42M | Hold |
163,064
| – | – | 0.01% | 557 |
|
|
2024
Q2 | $6.36M | Hold |
163,064
| – | – | 0.01% | 564 |
|
|
2024
Q1 | $7.02M | Sell |
163,064
-1,316
| -0.8% | -$56.7K | 0.01% | 540 |
|
|
2023
Q4 | $7.57M | Hold |
164,380
| – | – | 0.02% | 514 |
|
|
2023
Q3 | $5.62M | Hold |
164,380
| – | – | 0.01% | 535 |
|
|
2023
Q2 | $6.33M | Hold |
164,380
| – | – | 0.01% | 526 |
|
|
2023
Q1 | $5.88M | Hold |
164,380
| – | – | 0.01% | 524 |
|
|
2022
Q4 | $6.48M | Buy |
164,380
+50,900
| +45% | +$2.01M | 0.01% | 499 |
|
|
2022
Q3 | $4.1M | Buy |
113,480
+57,189
| +102% | +$2.06M | 0.01% | 571 |
|
|
2022
Q2 | $1.71M | Buy |
56,291
+47,771
| +561% | +$1.45M | ﹤0.01% | 863 |
|
|
2022
Q1 | $260K | Sell |
8,520
-28,595
| -77% | -$873K | ﹤0.01% | 1801 |
|
|
2021
Q4 | $1.16M | Buy |
37,115
+5,600
| +18% | +$175K | ﹤0.01% | 1198 |
|
|
2021
Q3 | $482K | Buy |
+31,515
| New | +$482K | ﹤0.01% | 1630 |
|